BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

AACR2020-BT-001
Jean-Baptiste Marchand et al.
AACR 2020
Download the poster here
Poster Presentation